Fluprednisolone (BioDeep_00000010025)
代谢物信息卡片
Pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-, (6.alpha.,11.beta.)-
化学式: C21H27FO5 (378.1842)
中文名称: 6-α-氟肾上腺素
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO
InChI: InChI=1S/C21H27FO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15-16,18,23,25,27H,4,6,8-10H2,1-2H3
描述信息
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
D000893 - Anti-Inflammatory Agents
Same as: D04227
同义名列表
数据库引用编号
15 个数据库交叉引用编号
- ChEBI: CHEBI:34474
- KEGG: C14618
- KEGGdrug: D04227
- PubChem: 5876
- PubChem: 3390
- Metlin: METLIN70208
- DrugBank: DB09378
- ChEMBL: CHEMBL1200774
- ChEMBL: CHEMBL4748027
- MeSH: Fluprednisolone
- CAS: 53-34-9
- PMhub: MS000023855
- PubChem: 17395618
- NIKKAJI: J4.143B
- KNApSAcK: 34474
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Zhi Wen, Jingfu Zhang, Guido Powell, Imane Chafi, David L Buckeridge, Yue Li. EpiTopics: A dynamic machine learning model to predict and inform non-pharmacological public health interventions from global news reports.
STAR protocols.
2022 06; 3(2):101463. doi:
10.1016/j.xpro.2022.101463. [PMID: 35712009] - Estelle Geffard, Léo Boussamet, Alexandre Walencik, Florent Delbos, Sophie Limou, Pierre-Antoine Gourraud, Nicolas Vince. HLA-EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities.
HLA.
2022 02; 99(2):79-92. doi:
10.1111/tan.14505. [PMID: 34862850] - Katelin Quantz, Amanda L Anderson, Christine D Harman, Erica L Noland, Jacquelyn M Del Valle, Laurence M Occelli, Jessica B Burn, Simon M Petersen-Jones, Daniel K Langlois, Chris G Pirie, Annette D Petersen, András M Komáromy. Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05\% ophthalmic emulsion (Durezol®).
BMC veterinary research.
2021 Dec; 17(1):366. doi:
10.1186/s12917-021-03072-9. [PMID: 34847929] - Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Parvin Moghaddam, Azadeh Zahmatkesh, Masoumeh Bagheri, Homayoon Mahravani. Are Epitopic Sites of 3AB and 3D Nonstructural Proteins Sufficient for Detection of Foot and Mouth Disease?.
Viral immunology.
2021 03; 34(2):79-85. doi:
10.1089/vim.2020.0144. [PMID: 33296262] - Anubhab Laha, Rajib Bandopadhyay, Anindya Sundar Panja. Structural Phylogeny of Different Allergens May Reveal Common Epitopic Footprint.
Protein and peptide letters.
2021; 28(10):1099-1107. doi:
10.2174/0929866528666210622145710. [PMID: 34161203] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - H K Knych, L Harrison, N Chouicha, P H Kass. Expression of inflammatory and structural matrix genes in synovial fluid following intra-articular administration of isoflupredone acetate to exercised horses.
Equine veterinary journal.
2018 Jul; 50(4):504-512. doi:
10.1111/evj.12771. [PMID: 29044706] - Heather K Knych, Linda M Harrison, Alexandria White, Daniel S McKemie. Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra-articular administration to exercised Thoroughbred horses.
Drug testing and analysis.
2016 Jan; 8(1):141-7. doi:
10.1002/dta.1834. [PMID: 26333097] - Anton M Kolomeyer, Shyam Kodati. Lamotrigine-induced tubulointerstitial nephritis and uveitis-atypical Cogan syndrome.
European journal of ophthalmology.
2015 Dec; 26(1):e14-6. doi:
10.5301/ejo.5000674. [PMID: 26350991] - P D Constable, M W H Hiew, S Tinkler, J Townsend. Efficacy of oral potassium chloride administration in treating lactating dairy cows with experimentally induced hypokalemia, hypochloremia, and alkalemia.
Journal of dairy science.
2014 Mar; 97(3):1413-26. doi:
10.3168/jds.2013-6982. [PMID: 24377802] - Tetsuya Tajika, Mitsunori Waki, Masakatsu Tsuzuki, Tetsuo Kida, Hideyuki Sakaki. Pharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassay.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
2011 Feb; 27(1):29-34. doi:
10.1089/jop.2010.0106. [PMID: 21182429] - Tetsuya Tajika, Akiharu Isowaki, Hideyuki Sakaki. Ocular distribution of difluprednate ophthalmic emulsion 0.05\% in rabbits.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
2011 Feb; 27(1):43-9. doi:
10.1089/jop.2010.0093. [PMID: 21118027] - H A Seifi, S J LeBlanc, E Vernooy, K E Leslie, T F Duffield. Effect of isoflupredone acetate with or without insulin on energy metabolism, reproduction, milk production, and health in dairy cows in early lactation.
Journal of dairy science.
2007 Sep; 90(9):4181-91. doi:
10.3168/jds.2006-897. [PMID: 17699036] - Natalie J Coffer, Nicholas Frank, Sarah B Elliott, Charles D Young, Sarel R van Amstel. Effects of dexamethasone and isoflupredone acetate on plasma potassium concentrations and other biochemical measurements in dairy cows in early lactation.
American journal of veterinary research.
2006 Jul; 67(7):1244-51. doi:
10.2460/ajvr.67.7.1244. [PMID: 16817750] - Masazumi Yamaguchi, Shin-ichi Yasueda, Akiharu Isowaki, Makiko Yamamoto, Masako Kimura, Katsuhiro Inada, Akira Ohtori. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate.
International journal of pharmaceutics.
2005 Sep; 301(1-2):121-8. doi:
10.1016/j.ijpharm.2005.05.036. [PMID: 16023810] - V Picandet, R Léguillette, J P Lavoie. Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ('heaves').
Equine veterinary journal.
2003 Jun; 35(4):419-24. doi:
10.2746/042516403776014208. [PMID: 12880012] - J D Lillich, A L Bertone, L M Schmall, A J Ruggles, R A Sams. Plasma, urine, and synovial fluid disposition of methylprednisolone acetate and isoflupredone acetate after intra-articular administration in horses.
American journal of veterinary research.
1996 Feb; 57(2):187-92. doi:
NULL. [PMID: 8633806] - H M McLean, M A Khalil, A S Heiman, H J Lee. Novel fluorinated antiinflammatory steroid with reduced side effects: methyl 9 alpha-fluoroprednisolone-16-carboxylate.
Journal of pharmaceutical sciences.
1994 Apr; 83(4):476-80. doi:
10.1002/jps.2600830406. [PMID: 7913964] - J F Vanderijst, B Vandeleene, J F De Plaen, J Kolanowski. An unusual cause of factitious mineralocorticoid excess.
Acta clinica Belgica.
1992; 47(6):408-13. doi:
10.1080/17843286.1992.11718263. [PMID: 1283935] - M C Maresca, G Calconi, G P Amici, T Teodori, A Da Porto. [Hypopotassemia and rhabdomyolysis. Description of 3 cases of different etiologies].
Minerva medica.
1988 Jan; 79(1):55-60. doi:
NULL. [PMID: 3340316] - V Foresti, E Parisio, G Ricci. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
Minerva medica.
1987 Sep; 78(17):1305-11. doi:
. [PMID: 2444906] - P T Scarpelli, L Scarpelli, R Livi, E Groppi, G Cornélissen, S Romano, M Cagnoni, F Halberg. Autometrically and automatically monitored, iatrogenous, inhalant-decongestant-associated high blood pressure quantified by rhythmometry.
Progress in clinical and biological research.
1987; 227B(?):183-200. doi:
NULL. [PMID: 2442774] - C D Spence, D P Campbell, J P Coghlan, D A Denton, E H Mills, M A Nelson, J A Whitworth, B A Scoggins. Structure-activity relationships for blood pressure effects of prednisolone in sheep.
Clinical and experimental hypertension. Part A, Theory and practice.
1987; 9(4):773-95. doi:
10.3109/10641968709161449. [PMID: 3621626] - T Higuchi, Y Kurashima, H Miida, M Higuchi. [Chronic toxicity study on difluprednate in dogs].
The Journal of toxicological sciences.
1985 May; 10(2):107-34. doi:
10.2131/jts.10.107. [PMID: 4032501] - J P Coghlan, D A Denton, E H Mills, M A Nelson, C D Spence, J A Whitworth, B A Scoggins. Steroid antagonism of the 'hypertensinogenic' activity of 9 alpha-fluoroprednisolone.
Life sciences.
1984 Dec; 35(26):2609-12. doi:
10.1016/0024-3205(84)90028-6. [PMID: 6513729] - Y Aizawa, H Kogo, K Yamada, N Inazu, T Matsudaira. [Effect of difluprednate on adrenocortical and gonadal function].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
1984 Dec; 84(6):553-61. doi:
10.1254/fpj.84.553. [PMID: 6519585] - J Montoliu, A Botey, A Trilla, L Revert. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
Clinical nephrology.
1984 Nov; 22(5):262-6. doi:
NULL. [PMID: 6394185] - H Rama, L Carreras, A Martínez-Amenos, X Sarrias. [Hypermineralocorticism secondary to the topical use of corticoids].
Revista clinica espanola.
1984 Aug; 174(3-4):111-4. doi:
NULL. [PMID: 6515071] - R Cantello, L Bergamini, M Delsedime, L Durelli, W Troni, M Gilli, D Cocito. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].
Minerva medica.
1983 Jun; 74(25):1463-7. doi:
NULL. [PMID: 6856155] - F Mantero. Exogenous mineralocorticoid-like disorders.
Clinics in endocrinology and metabolism.
1981 Nov; 10(3):465-78. doi:
10.1016/s0300-595x(81)80008-4. [PMID: 6178539] - F Mantero, D Armanini, G Opocher, F Fallo, L Sampieri, B Cuspidi, C Ambrosi, G Faglia. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
The American journal of medicine.
1981 Sep; 71(3):352-7. doi:
10.1016/0002-9343(81)90150-9. [PMID: 6169277] - F Vasconez, R Pérez-Garcia, E Olivas, J E Bolívar, F Valderrábano. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)].
Medicina clinica.
1980 Dec; 75(10):430-4. doi:
NULL. [PMID: 7464329] - W R Adam. Aldosterone and dopamine receptors in the kidney: sites for pharmacologic manipulation of renal function.
Kidney international.
1980 Nov; 18(5):623-35. doi:
10.1038/ki.1980.180. [PMID: 6257964] - H Armbruster, W Vetter, G Reck, R Beckerhoff, W Siegenthaler. Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
International journal of clinical pharmacology and biopharmacy.
1975 Jul; 12(1-2):170-3. doi:
NULL. [PMID: 51837] - L F Krzeminski, B L Cox, D D Hagg. Residue determination of 9alpha-fluoroprednisolone acetate and its metabolite 9alpha-fluoroprednisolone in bovine tissues.
Journal of agricultural and food chemistry.
1974 Sep; 22(5):882-5. doi:
10.1021/jf60195a035. [PMID: 4418971] - R A Ball, D G Topel, D N Marple, C L Annis. Glucocorticoid induced stress susceptibility in swine: adrenocortical pathology.
Canadian journal of comparative medicine : Revue canadienne de medecine comparee.
1974 Apr; 38(2):153-9. doi:
". [PMID: 4274821] - F L Lorscheider, G J Mears. Effects of extended lactation and 9 alpha-fluoroprednisolone acetate on serum thyroxine and lactational performance.
The Journal of endocrinology.
1973 Sep; 58(3):393-403. doi:
10.1677/joe.0.0580393. [PMID: 4795504] - M Ibrahim, P Guay, P Lamothe. [Electrolytes of the blood and endometrial secretions of the cow following glucocorticoid therapy].
Canadian journal of comparative medicine : Revue canadienne de medecine comparee.
1972 Apr; 36(2):160-6. doi:
. [PMID: 4259930] - J D Vlachos. A new experimental model of polycystic kidneys. Similarity to a human variety.
American journal of diseases of children (1960).
1972 Feb; 123(2):118-20. doi:
10.1001/archpedi.1972.02110080096007. [PMID: 5025857] - G Fiegel, D Kukwa. [Fluprednisolone, a corticosteroid of slight diabetogenic effect].
Arzneimittel-Forschung.
1970 Jun; 20(6):864-5. doi:
NULL. [PMID: 5468909] - J Haleblian, W McCrone. Pharmaceutical applications of polymorphism.
Journal of pharmaceutical sciences.
1969 Aug; 58(8):911-29. doi:
10.1002/jps.2600580802. [PMID: 4899118] - G Fiegel. [Behavior of serum-electrolytes under the effect of fluprednisolone].
Arzneimittel-Forschung.
1969 Jul; 19(7):1152-3. doi:
NULL. [PMID: 5394520] - G Fiegel. [Experimental results on the diabetogenic effect of fluprednisolone in the corticoid-glucose-tolerance-test].
Arzneimittel-Forschung.
1969 Jul; 19(7):1153-5. doi:
NULL. [PMID: 5394521] - Z Laron, A Pertzelan. The comparative effect of 6 alpha-fluoroprednisolone, 6 alpha-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease.
The Journal of pediatrics.
1968 Nov; 73(5):774-82. doi:
10.1016/s0022-3476(68)80189-1. [PMID: 4300675] - V P Hollander, K Takakura, H Yamada. Endocrine factors in the pathogenesis of plasma cell tumors.
Recent progress in hormone research.
1968; 24(?):81-137. doi:
10.1016/b978-1-4831-9827-9.50009-5. [PMID: 4302431] - L Gardoni, L Brunelli. [Intermittent corticosteroid therapy (single dose every 48 hours) in pediatrics].
Minerva pediatrica.
1967 May; 19(21):1017-9. doi:
NULL. [PMID: 5609616] - D EXLEY, J K NORYMBERSKI. URINARY EXCRETION OF 17-DEOXYCORTICOSTEROIDS BY MAN.
The Journal of endocrinology.
1964 Jun; 29(?):293-302. doi:
10.1677/joe.0.0290293. [PMID: 14200364]
